These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 25996881)
1. Renal transplantation experience in a patient with factor V Leiden homozygous, MTHFR C677T heterozygous, and PAI heterozygous mutation. Gülhan B; Tavil B; Gümrük F; Aki TF; Topaloglu R Pediatr Transplant; 2015 Aug; 19(5):E126-9. PubMed ID: 25996881 [TBL] [Abstract][Full Text] [Related]
2. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature. Lenicek Krleza J; Jakovljevic G; Bronic A; Coen Herak D; Bonevski A; Stepan-Giljevic J; Roic G Pathophysiol Haemost Thromb; 2010; 37(1):24-9. PubMed ID: 20664190 [TBL] [Abstract][Full Text] [Related]
3. A newborn case of intestinal infarction with homozygous MTHFR C677T and heterozygous of factor V Leiden G1691A, PAL-1 4G/5G mutations. Sandal G; Duman L; Ayata A Genet Couns; 2014; 25(1):81-4. PubMed ID: 24783662 [No Abstract] [Full Text] [Related]
4. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients. Wahba MA; Ismail MA; Saad AA; Habashy DM; Hafeez ZM; Boshnak NH Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385 [TBL] [Abstract][Full Text] [Related]
5. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India. Nishank SS; Singh MP; Yadav R Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124 [TBL] [Abstract][Full Text] [Related]
6. Renal vascular sclerosis is associated with inherited thrombophilias. Goforth RL; Rennke H; Sethi S Kidney Int; 2006 Aug; 70(4):743-50. PubMed ID: 16760910 [TBL] [Abstract][Full Text] [Related]
7. Impact of inherited thrombophilia on the risk of recurrent venous thromboembolism onset in Georgian population. Pirtskhelani N; Kochiashvili N; Makhaldiani L; Pargalava N; Gaprindashvili E; Kartvelishvili K Georgian Med News; 2014 Feb; (227):93-7. PubMed ID: 24632656 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians. Eid SS; Rihani G Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage. Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533 [TBL] [Abstract][Full Text] [Related]
10. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Yenicesu GI; Cetin M; Ozdemir O; Cetin A; Ozen F; Yenicesu C; Yildiz C; Kocak N Am J Reprod Immunol; 2010 Feb; 63(2):126-36. PubMed ID: 19906129 [TBL] [Abstract][Full Text] [Related]
11. Two cousins with neonatal stroke, PAI-1 4G variant and MTHFR A1298C mutation. Golomb MR; Heiny M; Garg BP J Child Neurol; 2007 Jun; 22(6):753-5. PubMed ID: 17641264 [TBL] [Abstract][Full Text] [Related]
12. Successful Living-Related Renal Allograft in a Recipient With Factor V Leiden Deficiency: A Case Report. Florou E; Koukoulaki M; Theodoros T; Kalatzis V; Vougas V; Stamataki E; Kokkinou VC; Kostakis A; Drakopoulos S Exp Clin Transplant; 2017 Feb; 15(1):96-99. PubMed ID: 26102090 [TBL] [Abstract][Full Text] [Related]
13. Thrombophilia in infancy: factor V Leiden and MTHFR or factor II double heterozygocity as a risk factor. Koren A; Levin C; Hujirat Y; El-Hasid R; Kutai M; Lanir N; Shalev S; Brenner B Pediatr Hematol Oncol; 2003; 20(3):219-27. PubMed ID: 12637218 [TBL] [Abstract][Full Text] [Related]
14. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion. Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919 [TBL] [Abstract][Full Text] [Related]
15. Peripartum thromboprophylaxis for homozygous and heterozygous FVL mutation carriers yields similar pregnancy outcome. Gat I; Dulitzki M; Schiff E; Sivan E; Simchen MJ Isr Med Assoc J; 2014 Feb; 16(2):96-100. PubMed ID: 24645228 [TBL] [Abstract][Full Text] [Related]
16. [Incidence of thrombophilia and risk of renal vessel thrombosis in kidney transplant recipients]. Toronyi E; Máthé Z; Chmel R; Varga M; Kozma V; Trent R; Tozsér G; Nagy G; Langer R Magy Seb; 2011 Oct; 64(5):229-34. PubMed ID: 21997526 [TBL] [Abstract][Full Text] [Related]
17. Successful renal transplantation in a patient with heterozygous prothrombin gene, factor V Leiden mutation and heparin-induced thrombocytopenia using r-hirudin as anticoagulant. John U; Kentouche K; Nowak G; Schubert J; Misselwitz J Pediatr Transplant; 2006 Feb; 10(1):114-8. PubMed ID: 16499600 [TBL] [Abstract][Full Text] [Related]
18. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis. Glueck CJ; Wang P Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459 [TBL] [Abstract][Full Text] [Related]
19. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk. Ziakas PD; Poulou LS; Pavlou M; Zintzaras E Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():106-11. PubMed ID: 26115054 [TBL] [Abstract][Full Text] [Related]
20. Combined germline variations of thrombophilic genes promote genesis of lung cancer. Ozen F; Polat F; Arslan S; Ozdemir O Asian Pac J Cancer Prev; 2013; 14(9):5449-54. PubMed ID: 24175756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]